Paradigms for adrenal cancer: Think globally, act locally

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 11, 2006, Pages 4250-4252

  Kirschner, Lawrence S ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ETOPOSIDE; MITOTANE; PLATINUM; STREPTOZOCIN;

ADJUVANT THERAPY; ADRENAL CORTEX CARCINOMA; BONE METASTASIS; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; EDITORIAL; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ADRENAL TUMOR; CARCINOMA; MORTALITY; NOTE; SURVIVAL RATE; THINKING;

ADRENAL GLAND NEOPLASMS; CARCINOMA; HUMANS; SURVIVAL RATE; THINKING;

EID: 33751512008     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1934     Document Type: Editorial

References (14)

1. Allolio B, Fassnacht M 2006 Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91:2027-2037
2. Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, DeLacerda L, Rabin M, Cadwell C, Sampaio G, Cat I, Stratakis CA, Sandrini R 2001 An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci USA 98:9330-9335
3. Ng L, Libertino JM 2003 Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 169:5-11
4. Dackiw AP, Lee JE, Gagel RF, Evans DB 2001 Adrenal cortical carcinoma. World J Surg 25:914-926
5. Kirschner LS 2006 Emerging treatment strategies for adrenocortical carcinoma: a new hope. J Clin Endocrinol Metab 91:14-21
6. Berruti A, Terzolo M, Pia A, Angeli A, Dogliotti L 1998 Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer. Cancer 83:2194-2200
7. Berruti A, Terzolo M, Sperone P, Pia A, Casa SD, Gross DJ, Carnaghi C, Casali P, Porpiglia F, Mantero F, Reimondo G, Angeli A, Dogliotti L 2005 Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. Endocr Relat Cancer 12:657-666
8. Khan TS, Imam H, Juhlin C, Skogseid B, Grondal S, Tibblin S, Wilander E, Oberg K, Eriksson B 2000 Streptozocin and o,p′DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use. Ann Oncol 11:1281-1287
9. Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, Worden FP 2005 Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12:667-680
10. Crucitti F, Bellantone R, Ferrante A, Boscherini M, Crucitti P 1996 The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multi-institutional series of 129 patients. The ACC Italian Registry Study Group. Surgery 119:161-170
11. Wood BJ, Abraham J, Hvizda JL, Alexander HR, Fojo T 2003 Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 97:554-560
12. Percarpio B, Knowlton AH 1976 Radiation therapy of adrenal cortical carcinoma. Acta Radiol Ther Phys Biol 15:288-292
13. Fassnacht M, Hahner S, Polat B, Koschker AC, Kenn W, Flentje M, Allolio B 2006 Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. J Clin Endocrinol Metab 91:4501-4504
14. Schulick RD, Brennan MF 1999 Adrenocortical carcinoma. World J Urol 17:26-34